PATENT CLAIM ANALYSIS

Application Number: 15885197
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["424", "204100"]

Abstract:
Embodiments of the disclosure concern methods and compositions for immunotherapy for human papillomavirus infection and diseases associated therewith. In specific embodiments, methods concern production of immune cells that target one or more antigens of HPV16 and/or HPV18, including methods with stimulation steps that employ IL-7 and IL-15, but not IL-6 and/or IL-12. Other specific embodiments utilize stimulations in the presence of certain cells, such as costimulatory cells and certain antigen presenting cells.

Claim (Index 39):
The method according to  claim 38 , wherein the one or more HPV antigens are selected from E1, E2, E3, E4, E5, E6 and E7.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.43636
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15331659', '14453286', '14364592', '15678970', '12451983']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7462849738927566
- 35 USC 102 Novelty (BERT): 0.5626015823380176
- Combined Prediction Score: 0.7279166347372827
- Mean Citation Score: 355.407312
- Max Citation Score: 460.05124000000006
- Similarity Product: 301.5458987389088

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test